NASDAQ · AEMD
Aethlon Medical, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for AEMD: Nov 11, 2026
Aethlon Medical, Inc. Common Stock is estimated to report earnings on 11/11/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-2.91. The reported EPS for the same quarter last year was $-18.7.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-2.91 | $-2.17 | $-3.64 | 2 |
| Dec 2026 | $-1.14 | $-0.12 | $-2.17 | 2 |
| Mar 2027 | $-1.16 | $-0.14 | $-2.18 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Fintel- RTTNews · Sep 18, 10:44 AM EDTWeekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead(RTTNews) – Biotech investors tracked a busy week marked by regulatory approvals, strategic collaborations, workforce restructuring and key clinical trial readouts.
- RTTNews · Sep 17, 2:28 PM EDTBiotech Stocks In Focus: Aethlon, Tiziana, Capricor, Firefly & Clearmind(RTTNews) – Biotech stocks were in focus Thursday following a series of company updates, including Aethlon Medical's proposed merger with North Immunology, Tiziana Life Sciences' MS trial collaboration, Capricor's upcoming Duchenne data, Firefly Neuroscience's brain-medicine part
- RTTNews · Sep 17, 7:01 AM EDTAethlon Medical Shares Surge Over 470% On North Immunology Merger, $180M Financing(RTTNews) – Aethlon Medical, Inc. (AEMD) shares are surging more than 470% after the company announced a definitive all-stock merger agreement with North Immunology, along with an oversubscribed $180 million private placement.
- RTTNews · Aug 28, 3:14 PM EDTBiotech Gainers: QNRX Leads Gains As AEMD, DWTX And FRNM Report Key Developments(RTTNews) – Today's top gainers in the biotech and healthcare space include Aethlon Medical, following narrower quarterly losses and progress in its Hemopurifier oncology study; Quoin Pharmaceuticals, on positive QRX003 data and a $50 million financing; Dogwood Therapeutics, as i
- RTTNews · Aug 28, 6:29 AM EDTAethlon Posts Narrower Q1 Loss, Stock Jumps(RTTNews) – Aethlon Medical, Inc. (AEMD), a clinical-stage medtech company, recently reported a narrower net loss for the first quarter ended June 30, 2026, due to lower operating expenses and higher interest income, compared to the prior year.
- RTTNews · Jul 6, 10:45 AM EDTAethlon Medical Prices $4 Million Follow-On Offering(RTTNews) – Aethlon Medical, Inc. (AEMD) announced it has priced a $4.0 million follow-on public offering, structured at-the-market under Nasdaq rules.
- The Motley Fool · Jun 10, 6:15 PM EDTAethlon (AEMD) Q4 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · May 26, 6:50 AM EDTAethlon Medical Reaffirms Regulatory Engagement Plans For Hemopurifier; Stock Up(RTTNews) – Aethlon Medical, Inc. (AEMD), a clinical-stage medical device firm, announced that it is prepared to engage with global healthcare and regulatory authorities regarding the potential investigational use of its Hemopurifier technology, as it is currently monitoring deve
- Fintel · Oct 29, 9:55 AM EDTAethlon Medical (AEMD) Price Target Increased by 309.09% to 12.62The average one-year price target for Aethlon Medical (NasdaqCM:AEMD) has been revised to $12.62 / share. This is an increase of 309.09% from the prior estimate of $3.09 dated September 27, 2025. The price target is an average of many targets provided by analy
- RTTNews · Sep 4, 10:54 PM EDTAethlon Medical Prices $4.5 Mln Public Offering Of Common Stock And Warrants(RTTNews) – Aethlon Medical, Inc. (AEMD), a company developing therapies for cancer and infectious diseases, has priced a public offering of 5,000,000 shares of common stock or pre-funded warrants and accompanying warrants to purchase up to 5,000,000 shares at $0.90 per unit.
- RTTNews · Sep 3, 6:48 PM EDTAethlon Secures Patents For Hemopurifier Use In Long COVID And CAC Treatments(RTTNews) – Aethlon Medical, Inc. (AEMD) announced that U.S. Patent No. 12,409,260, covering the use of its Hemopurifier for Long COVID treatment, will issue on September 9, 2025.
- The Motley Fool · Aug 13, 5:45 PM EDTAethlon Medical Cuts Loss in Fiscal Q1GAAP EPS loss improved to $(0.85) for Q1 FY2026, beating the consensus estimate of $(0.86) and narrowing from $(2.76) in Q1 FY2025.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Aethlon Medical, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.